Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|April 19, 2017
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomasSophie Weil, Matthias Osswald, Gergely Solecki, et al.
Artificial Organs|January 13, 2005
Contact activation in low-density lipoprotein apheresis systemsDetlef H Krieter, Jörn Steinke, Markus Kerkhoff, et al.
Artificial Organs|November 14, 2012
Bisphenol A in chronic kidney diseaseDetlef H Krieter, Bernard Canaud, Horst-Dieter Lemke, et al.
Annals of Neurology|January 11, 2007
Synergistic antiglioma activity of radiotherapy and enzastaurinGhazaleh Tabatabai, Brigitte Frank, Antje Wick, et al.
Plos One|February 12, 2014
HERG K+ channel-dependent apoptosis and cell cycle arrest in human glioblastoma cellsIngo Staudacher, Julian Jehle, Kathrin Staudacher, et al.
Nephrologie & Therapeutique|July 30, 2014
Uremic toxicity and sclerostin in chronic kidney disease patientsLucie Desjardins, Sophie Liabeuf, Rodriguo B Oliveira, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2011
Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalitiesNatalie Meert, Sunny Eloot, Eva Schepers, et al.
Kidney International|August 17, 2012
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patientsSophie Liabeuf, Aurélie Lenglet, Lucie Desjardins, et al.
Kidney International|December 18, 2009
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney diseaseDaniela V Barreto, Fellype C Barreto, Sophie Liabeuf, et al.
The International Journal of Artificial Organs|October 16, 2012
Prognostic implications of plasma myoglobin levels in patients with chronic kidney diseaseAurélie Lenglet, Sophie Liabeuf, Lucie Desjardins, et al.
Pageof 6